BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7041911)

  • 1. Preliminary characterization of the adducts formed between the antitumor compounds cis-Pt(NH3)2Cl2 and DNA.
    Johnson NP
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1394-400. PubMed ID: 7041911
    [No Abstract]   [Full Text] [Related]  

  • 2. cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells.
    Salles B; Butour JL; Lesca C; Macquet JP
    Biochem Biophys Res Commun; 1983 Apr; 112(2):555-63. PubMed ID: 6682656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA.
    Blatter EE; Vollano JF; Krishnan BS; Dabrowiak JC
    Biochemistry; 1984 Oct; 23(21):4817-20. PubMed ID: 6541947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments.
    Brabec V; Vrana O; Kiseleva VI; Poverenny AM
    Eur J Biochem; 1991 Nov; 201(3):723-30. PubMed ID: 1935966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity, cytotoxicity, and DNA binding of platinum(II)-chloroammines in Chinese hamster ovary cells.
    Johnson NP; Hoeschele JD; Rahn RO; O'Neill JP; Hsie AW
    Cancer Res; 1980 May; 40(5):1463-8. PubMed ID: 7189447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in Escherichia coli K-12 cells treated with cis-diamminedichloroplatinum(II).
    Brouwer J; Fichtinger-Schepman AM; van de Putte P; Reedijk J
    Cancer Res; 1982 Jun; 42(6):2416-9. PubMed ID: 7042085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II).
    Beck DJ; Popoff S; Sancar A; Rupp WD
    Nucleic Acids Res; 1985 Oct; 13(20):7395-412. PubMed ID: 3903663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
    Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner and outer complexes of Pt-coordination compounds with DNA probed by SERS spectroscopy.
    Séquaris JM; Koglin E; Malfoy B
    FEBS Lett; 1984 Jul; 173(1):95-8. PubMed ID: 6540207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thermodynamics of translesion DNA synthesis past major adducts of enantiomeric analogues of antitumor cisplatin.
    Malina J; Novakova O; Natile G; Brabec V
    Chem Asian J; 2012 May; 7(5):1026-31. PubMed ID: 22374916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.
    Fichtinger-Schepman AM; Dijt FJ; Bedford P; van Oosterom AT; Hill BT; Berends F
    IARC Sci Publ; 1988; (89):321-8. PubMed ID: 3198216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
    Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
    Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of antitumour drug cis-Pt(NH3)2C12 to DNA rich in guanine and cytosine.
    Stone PJ; Kelman AD; Sinex FM
    Nature; 1974 Oct; 251(5477):736-7. PubMed ID: 4427676
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the excision-repair enzymes in mutation-induction by cis-Pt(NH3)2Cl2.
    Brouwer J; Vollebregt L; van de Putte P
    Nucleic Acids Res; 1988 Aug; 16(15):7703-11. PubMed ID: 3045762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between chelated and non-chelated DNA-Pt complexes by atomic absorption spectrophotometry.
    Macquet JP; Theophanides T
    Biochim Biophys Acta; 1976 Aug; 442(2):142-6. PubMed ID: 953006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
    Payet D; Gaucheron F; Sip M; Leng M
    Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.